Research

An ongoing genome-wide association study (GWAS) to identify genetic risk factors for ME/CFS.

Despite the high burden of disease, ME/CFS research is decades behind. A lack of funding and methodological shortcomings have led to a massive research gap. The website provides a brief summary of this situation.

Funding opportunities and donations at the German Society for ME/CFS.

A new study investigates the role of inflammatory, immune and receptor-based biomarkers in ME/CFS.

The page for the current conference with links to the video contributions.

Overview of current Long Covid research in Germany.

The latest overview of ME/CFS research in Germany and Austria can be found on the ResearchFoundation website.

The ME/CFS Research Register provides an overview of medical research on ME/CFS. It contains lists and detailed descriptions of research projects, research networks, publications and scientific events, as well as types of research, research areas, working groups, individuals and organisations associated with ME/CFS research.

A study by the University of Edinburgh shows clear biological indicators for ME/CFS in the blood for the first time. These findings refute the assumption that ME/CFS is caused by inactivity.

The National Clinical Trials Group (NCTG) is an interdisciplinary network of physicians and scientists with the goal of developing translational research and therapeutic trials for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-COVID-19 syndrome (PCS).

Latest research news from the website of the German Society for ME/CFS.

A US study comprehensively investigated the pathophysiology of ME/CFS and found significant multisystemic changes. These include immune abnormalities, reduced microbial diversity, neurophysiological dysfunctions and autonomic disorders.

Basics of organic changes in ME/CFS. Autoantibodies as a possible cause are also discussed.

PubMed is a free resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally. Here you can research studies of ME/CFS.

A study using rituximab for ME/CFS.

Our own page with the option to donate and set up your own fundraising campaigns.

Current fundraising campaign by Lottie (Vis a Vie) for ME/CFS.

Double-blind, placebo-controlled, two-arm, phase 2a study in a parallel group design to demonstrate improvement in physical function in the SF-36 in patients with post-COVID-19 syndrome treated with vericiguat compared to placebo (VERI-LONG).

The Foundation's study on the social costs of PAIS in Germany.

Prof. Wirth's latest research on ME/CFS as acquired mitochondrial dysfunction.